Although antimicrobial products are essential for treating diseases caused by bacteria, antimicrobial treatment selects for antimicrobial-resistant (AMR) bacteria. The aim of this study was to determine the effects of administration of first-generation cephalosporins on development of resistant Escherichia coli in dog feces. The proportions of cephalexin (LEX)-resistant E. coli in fecal samples of three healthy dogs treated i.v. with cefazolin before castration and then orally with LEX for 3 days post-operation (PO) were examined using DHL agar with or without LEX (50 mg/mL). LEX-resistant E. coli were found within 3 days PO, accounted for 100% of all identified E. coli 3-5 days PO in all dogs, and were predominantly found until 12 days PO. LEX-resistant E. coli isolates on DHL agar containing LEX were subjected to antimicrobial susceptibility testing, pulsed-field gel electrophoresis (PFGE) genotyping, b-lactamase typing and plasmid profiling. All isolates tested exhibited cefotaxime (CTX) resistance (CTX minimal inhibitory concentration !4 mg/mL). Seven PFGE profiles were classified into five groups and three b-lactamase combinations (bla CMY-4 -bla TEM-1 , bla TEM-1 -bla CTX-M-15 and bla TEM-1 -bla CTX-M-15 -bla CMY-4 ). All isolates exhibited identical PFGE profiles in all dogs on four days PO and subsequently showed divergent PFGE profiles. Our results indicate there are two selection periods for AMR bacteria resulting from the use of antimicrobials. Thus, continuing hygiene practices are necessary to prevent AMR bacteria transfer via dog feces after antimicrobial administration.
thus in close contact with humans. Numerous studies have reported transmission of pathogenic and/or AMR bacteria from companion animals to their owners (3, 4) . Therefore, when veterinarians must use or prescribe antimicrobials, they should also give their owners information on controlling AMR bacteria.
It is important to generate information regarding the public health impact of antimicrobial usage in companion animals. In particular, b-lactam antibiotics are commonly used for therapeutic purposes in both small animal (5) and human medicine. Some studies have reported selection of AMR bacteria by use of b-lactam antibiotics such as penicillin, and first-or third-generation cephalosporins in dogs (6) (7) (8) (9) . Use of these antibiotics thus has the potential to select for BSC-resistant bacteria such as extended-spectrum b-lactamase producers, creating a serious threat in human medicine (9) . However, longitudinal studies on selection periods after antimicrobial administration are limited to amoxicillin (6) and cefovecin (9) , which is a long-acting veterinary BSC antibiotic. In this study, we determined the effects of firstgeneration cephalosporin administration on shedding periods for resistant E. coli in feces of dogs.
MATERIALS AND METHODS

Animals and sampling
This study utilized three male beagle dogs, kept at Gifu University as laboratory animals and subject to castration for surgical training of veterinary students. One dog (No. 1, BW: 13.5 kg) was 2 years old and the remaining two dogs (No. 2 and No. 3, 15 kg and 12.8 kg, respectively) were 8 months old. The training was approved by the Animal Care and Use Committee for Animal Experimentation of Gifu University (No. 13020). The dogs had no history of antimicrobial treatment in the previous 6 months, were fed the same regular canine maintenance diet (TC-2; Oriental Yeast, Tokyo, Japan), and were kept in individual open-air kennels. The dogs were injected i.v. with cefazolin (Cefamezin a,; 20 mg/k; Astellas Pharma, Tokyo, Japan) before surgery. Subsequently, cephalexin (LEX) was administered orally at a dose of 250 mg/dog (Larixin; Toyama Pharmaceutical, Toyama, Japan) twice daily for 3 days PO. The dogs were housed in separate cages in a room for 3 days PO and were then moved to their own kennels. Fecal samples were collected every day prior to surgery (day 0) and until 14 days PO.
Bacterial isolation and identification
For bacterial isolation, 500 mg of feces was mixed with 4.5 mL of sterile physiological saline followed by 10-fold serial dilution of the mixtures. Each diluted sample (50 mL) was spread on DHL agar plates (Eiken Chemical, Tokyo, Japan)containing 50 mg/mL LEX (Sigma Chemical, St. Louis, MO, USA) and on DHL agar plates without LEX. Following overnight incubation at 37°C, lactosepositive colonies on DHL agar plates with and without LEX were counted and the number of coliform bacteria enumerated as CFU/g feces. The bacteria that grew on DHL agar plates with LEX were defined as LEX-resistant. A maximum of 10 discrete colonies per dog per sample was picked from the DHL agar plates containing LEX from the highest culture dilution in each case; the isolates were stored at À80°C in Microbank vials (Iwaki, Tokyo, Japan) until use. The isolates were confirmed to be E. coli by the API-20E system (Sysmex BioM erieux, Tokyo, Japan).
Antimicrobial susceptibility testing
MICs were determined using a commercially available broth microdilution test (Eiken Chemical) according to the manufacturer's instructions. The following antimicrobial agents were tested: AMP (range of antimicrobial dilution: 1-128 mg/mL), CFZ (1-128), CTX (0.5-64), STR (1-128), GEN (0.5-64), KAN (1-128), TET (0.5-64), NAL (1-128), CIP (0.03-4), CST (0.12-16), CHL (1-128) and TMP (0. . Staphylococcus aureus ATCC29213 and E. coli ATCC25922 were used for quality control according to the guidelines of the Clinical and Laboratory Standards Institute (10) . Clinical and Laboratory Standards Institute resistance breakpoints were used in the categorical analysis of all drugs except for STR and CST (11) . The European Committee on Antimicrobial Susceptibility Testing resistance breakpoint was used for CST and their epidemiological cut-off for STR as the breakpoint (12) .
Determination of the presence of the b-lactamase gene All isolates were analyzed for the presence of bla CTX , bla TEM , bla SHV , bla OXA and bla AmpC -like genes by multiplex PCR, as described previously (13) . Sequence analyses were performed using primer pairs for amplification of the full-length genes for isolates positive for CMY-2 group (14), CTX-M-1 group (15) and TEM group (14) genes. The PCR products were sequenced at the Life Sciences Research Center, Gifu University. The resulting nucleotide sequences were analyzed using BLAST available on the homepage of the National Center for Biotechnology Information (16) .
PFGE and phylogenetic analysis
All isolates were typed by PFGE using the XbaI restriction enzyme according to the PulseNet Cephalosporin-resistant E. coli in dog feces protocol (17) . Salmonella serotype Braenderup H9812 strain was used as the universal size standard. Electrophoresis was performed using a CHEF-DR III System (Bio-Rad, Hercules, CA, USA) with one phase from 2.2 to 63.8 s at 6 V/cm, 14°C for 18.5 hr. The Dice coefficients of the PFGE profiles were analyzed with an UPGMA dendrogram using GelCompar II version 6.6.11 (Applied Maths BVBA, Kortrijk, Belgium). Band comparison settings of 0.5% optimization and 1.0% band filtering tolerance were used. Isolates were grouped based on their similarity with a coefficient higher than 90% to show clonal relationships.
Plasmid characterization
Eight strains were selected based on the PFGE profile, the b-lactamase gene, and antimicrobial susceptibility, and subjected to plasmid conjugation testing. The pulsotype XA was shown by two AMP-CFZ-CTX-STR-GEN-KAN-TET-NAL-CIP-TMP-resistant strains (strains 51 and 106), one AMP-CFZ-CTX-STR-TET-TMP-resistant strain (strain 326) with bla TEM-1 -bla CTX-M-15 -bla CMY-4 and one AMP-CFZ-CTX-STR-TET-TMPresistant strain (strain 325) with bla TEM-1 -bla CTX-M-15 . The pulsotypes XC1, XB, XE and XD were shown by four AMP-CFZ-CTX-resistant strains (strains 140, 321, 238 and 342) with bla TEM-1 -bla CMY-4 . Transconjugants were established by filter mating methods, using E. coli DH5a (resistant to rifampicin and NAL) as a recipient strain (18) . PCR-based plasmid replicon typing was performed using primer sets described previously (19) .
Determination of qnr genes
The transconjugants were investigated for the presence of qnrA, qnrB, qnrC, qnrD, qnrS, aac(6)-Ib-cr and qepA by PCR amplification with primer sets described previously (20) . The PCR products for qnrS were sequenced.
RESULTS
LEX-resistant E. coli were first found in dog feces within 3 days PO. LEX-resistant bacteria accounted for 100% of all isolates in all dogs 3 and 5 days PO and were predominant for 10 days PO. On day 14 PO, the proportion of resistant bacteria had decreased in two of the three dogs (Fig. 1) .
UPGMA analysis classified seven PFGE profiles into five groups (groups XA to XE), as shown in Figure 2 . Group XC contained subgroups XC1, XC2 and XC3. The dominant LEX-resistant isolates from the three dogs showed identical PFGE patterns in all dogs on four days PO. In Dog 1, isolates of group XB were predominant during the periods from 2 to 4 days PO. In Dog 3, isolates of group XC1 were predominant on days 3-9 PO. In Dog 2, the predominant PFGE type was group XA on 3 days PO, group XB on 4 days PO, and group C1 on 5-7 days PO. After these periods, the isolates showed divergent PFGE patterns. In contrast, only three b-lactamase combinations were identified (Table 1) : bla TEM-1 -bla CMY-4 , bla TEM-1 -bla CTX-M-15 and bla TEM-1 -bla CTX-M-15 -bla CMY-4 . Additionally, bla TEM-1 -bla CMY-4 was found in groups XB, XC, XD and XE, and both bla TEM-1 -bla CTX-M-15 and bla TEM-1 -bla CTX-M-15 -bla CMY-4 in group XA isolates.
All isolates tested exhibited resistance to AMP, CFZ and CTX (Table 2 ). Resistance to STR, TET and TMP was found in the isolates of group XA. Resistance to GEN and KAN was found in some isolates carrying bla TEM-1 -bla CTX-M-15 -bla CMY-4 in group XA and with bla TEM-1 -bla CMY-4 in groups XB, XC, XD and XE.
Further analysis was performed on eight of the dominant isolates, which were selected on the basis of PFGE group and b-lactamase type, as shown in Table 3 . With respect to plasmid replicon type, bla TEM-1 -bla CMY-4 was located in IncA/C plasmids whereas bla TEM-1 -bla CTX-M-15 was located in IncFIB plasmids. Transconjugants with bla TEM-1 -bla CTX-M-15 exhibited resistance to STR, TET and TMP and low CIP susceptibility, for which qnrS1 was responsible.
DISCUSSION
This study showed that BSC-resistant strains of E. coli in the feces of dogs were selected within 3 days PO by the use of first-generation cephalosporin drugs and persisted for approximately 2 weeks PO. Similar selection of BSCresistant E. coli has been observed in dogs treated orally with LEX (25 mg/kg b.i.d.) (8) . In dogs that received AMX (10 mg/kg b.i.d.) orally for 7 days, AMX-resistant E. coli were reportedly selected within 2 to 7 days PO (6, 7). Additionally, resistant bacteria were predominantly observed from 7 to 28 days in dogs injected s.c. with cefovecin (8 mg/kg, once), which is a long-acting veterinary BSC antibiotic (9) . Thus, AMR bacteria appear to be commonly selected by the use of antimicrobials, although the emergent and persistent periods of AMR selection in dogs differ between drugs.
Our findings suggest that the use of antimicrobials resulted in two terms of antimicrobial selective force. Initially, a specific clone of AMR bacteria was rapidly selected in the feces of each dog in the presence of the antimicrobial selective force. Thereafter, predominance of BSC-resistant bacteria persisted with additional genetic divergence throughout the observation period. Although E. coli isolates with bla CMY-4 were commonly selected in all dogs tested during administration of LEX, the LEX MIC was higher for CTX-M-15 producers than for CMY-4 producers. A post-antibiotic effect has been demonstrated wherein bacterial growth is continues to be suppressed after the final administration of the antibiotic (21) . Although predominance of LEX-resistant E. coli persisted for 2 weeks PO, it was unclear whether this was attributable to a post-antibiotic effect or residual LEX in the dogs' intestines. Concentrations of administered antibiotics should be determined to clarify the reasons for the continued predominance of resistant bacteria after the final drug administration.
During the experiments, two identical clones of AMR E. coli, pulsotype XA isolates with bla TEM-1 and bla CTX-M-15 and pulsotype XB isolates with bla TEM-1 and bla CMY-4 , were found in all three dogs, implying horizontal transfer of AMR bacteria among dogs. All dogs used in this study were housed in separate cages in a room for 3 days PO, whereas they were kept in individual open-air kennels before surgery and after 4 days PO. In the open-air kennels, they were cared for by several practitioners who were wearing their own clothes and boots. Therefore, cross-contamination of bacteria, including AMR E. coli in the dogs' feces, may have occurred while the dogs were in the open-air kennels. We are continuing to examine the prevalence of BSCresistant E. coli in dogs kept in such kennels to clarify whether antimicrobial administration contributed to the presence of identical AMR E. coli in all three dogs.
Plasmid-mediated b-lactamase genes can disseminate to other bacteria via conjugation transfer (1) . In this study, bla CMY-4 was found in multiple PFGE profiles of LEX-resistant isolates, whereas bla CTX-M-15 was found in only a single PFGE isolate profile. In addition, conjugation tests revealed that STR, TET and TMP resistance transferred commonly with bla CTX-M-15 , but not with bla CMY-4 . Plasmids encoding b-lactamase often harbor multiple antimicrobial resistance genes (22) , resulting in co-selection of b-lactamase genes by the use of antimicrobials other than b-lactam antibiotics (2). However, as no antimicrobials were administered to the dogs after the final LEX administration in this study, the observed increase in bla CTX-M-15 -harboring E. coli was not associated with selection of co-resistance.
In the present study, bla CMY-4 and bla CTX-M-15 were responsible for BSC resistance in E. coli isolates selected after LEX administration. The bla CMY-4 gene was first identified in a Proteus mirabilis isolate from a human urine sample in Tunisia in 1996 (23); the gene was subsequently found in several other countries (24) (25) (26) . In the UK, the IncA/C plasmid carrying bla CMY-4 was reported in a Salmonella Senftenberg isolate of human origin in 2001 (24) . In addition, some studies have suggested that a combination of CMY-4 production with decreased permeability results in carbapenem resistance in bacteria (25, 26) . Information on bla CMY-4 -carrying P. mirabilis isolated from a clinical sample from a dog is now available in Japan (27) . In contrast, CTX-M-15 producers have been reported in E. coli and Salmonella from food-producing animals (15, (28) (29) (30) . CTX-M-15-producing E. coli were found in dogs in Japan in 2010 (31) . In addition, Klebsiella pneumoniae carrying bla CTX-M-15 together with some PMQR genes such as oqxAB, aac(6')-1b-cr and qnrB have been isolated from dogs since 2013 (32) . In this study, a combination of bla CTX-M-15 with qnrS1 was detected in BSC-resistant E. coli, whereas a combination of bla CTX-M-15 with oqxAB was frequently found in K. pneumoniae in a previous study (32) . The IncA/C and IncFIB plasmids encoding b-lactamase genes are widely prevalent in Enterobacteriaceae among humans and animals in several countries (33) . In the present study, IncFIB plasmids with multidrug resistance genes carried bla CTX-M-15 , bla TEM-1 and qnrS1, whereas IncA/C plasmids carried bla TEM-1 and bla CMY-4 . In Japan, bla CMY-2 -haboring IncA/C plasmids carrying multidrug resistance genes have been identified in BSC-resistant E. coli and S. typhimurium from broiler chickens and cattle, respectively (23, 34) . In contrast, IncF, including IncFIB, is a replicon type detected in bla CTX-M-15 -haboring plasmids (33) . Co-transfer of resistance genes responsible for TET, GEN and SXT resistance has been observed in a bla CTX-M-15 -harboring - †E. coli DH5a (rifampicin and NAL resistant) was used as a plasmid recipient strain; ‡see footnotes to Table 2 ; §MICs of ciprofloxacin increased from 0.06 mg/mL in the recipient strain to 0.5 mg/mL in the transconjugant strain.
IncF plasmid in E. coli from dogs (35, 36) . As fecal bacteria often cause urinary tract and genital infections in dogs, appropriate antimicrobials for preventing emergence of resistant bacteria and spread of resistance determinants during treatment should be selected.
This study showed that a selective force for AMR bacteria persisted for a few weeks after standard use of antimicrobials, indicating that AMR bacteria may be caused by factors other than drug overuse and misuse. Therefore, when veterinarians use and prescribe antimicrobials for bacterial disease, they should educate the owner in means of preventing transfer of AMR bacteria from their animals and limiting environmental pollution by AMR bacteria through fecal shedding.
